Pharmaceutical Composition Containing Botulinum Neurotoxin A2

Patent No. EP1776137 (titled "Pharmaceutical Composition Containing Botulinum Neurotoxin A2") was filed by Ipsen on Aug 3, 2005. The application was issued on Nov 26, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANAug 25, 2015DENISON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1776137

IPSEN
Application Number
EP05767871A
Filing Date
Aug 3, 2005
Status
Revoked
Publication Date
Nov 26, 2014